R. S. Aloyz, S. X. Bamji, C. D. Pozniak, J. G. Toma, J. Atwal et al., is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors, J. Cell Biol, vol.143, pp.1691-1703, 1998.

F. Barthel, A. L. Boutillier, P. Giraud, B. A. Demeneix, J. P. Behr et al., Gene regulation analysis by lipopolyaminemediated DNA transfer in primary neurons, Methods Neurosci, vol.9, pp.291-312, 1992.

U. Blomer, T. Kafri, L. Randolph-moore, I. M. Verma, and F. H. Gage, Bcl-xL protects adult septal cholinergic neurons from axotomized cell death, Proc. Natl. Acad. Sci. USA, vol.95, pp.2603-2608, 1998.

L. H. Boise, M. Gonzalez-garcia, C. E. Postema, M. Ding, T. Lindsten et al., Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, vol.74, pp.597-608, 1993.

L. I. Bruijn, M. W. Becher, M. K. Lee, K. L. Anderson, N. A. Jenkins et al., ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions, Neuron, vol.18, pp.327-338, 1997.

L. Buckbinder, R. Talbott, S. Velasco-miguel, I. Takenaka, B. Faha et al., Induction of the growth inhibitor IGF-binding protein 3 by p53, Nature, vol.377, pp.646-649, 1995.

S. M. De-la-monte, Y. K. Sohn, N. Ganju, and J. R. Wands, and CD95-associated apoptosis in neurodegenerative disease, Lab. Invest, vol.78, pp.401-411, 1998.

C. J. Di-como, C. Gaiddon, and C. Prives, function is inhibited by tumor-derived p53 mutants in mammalian cells, Mol. Cell. Biol, vol.19, pp.1438-1449, 1999.
URL : https://hal.archives-ouvertes.fr/inserm-02360310

T. Ekegren, E. Grundstrom, D. Lindholm, and S. M. Aquilonius, Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons, Acta Neurol. Scand, vol.100, pp.317-321, 1999.

J. V. Gannon and D. P. Lane, Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport, Nature, vol.349, pp.802-806, 1991.

F. Gillardon, L. Klimaschewski, H. Wickert, S. Krajewski, J. C. Reed et al., Expression pattern of candidate cell death effector proteins Bax, Bcl-2, Bcl-x and c-jun in sensory and motor neurons following sciatic nerve transection in the rat, Brain Res, vol.739, pp.244-250, 1996.

M. E. Gurney, H. Pu, A. Y. Chiu, M. C. Dal-canto, C. Y. Polchow et al., Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation, Science, vol.264, pp.1772-1775, 1994.

S. M. Hsu, L. Raine, and H. Fanger, Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures, J. Histochem. Cytochem, vol.29, pp.577-580, 1981.

R. P. Huang and E. D. Adamson, A biological role for Egr-1 in cell survival following ultra-violet irradiation, Oncogene, vol.10, pp.467-475, 1995.

V. Kostic, V. Jackson-lewis, F. De-bilbao, M. Dubois-dauphin, and S. Przedborski, Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis, Science, vol.277, pp.559-562, 1997.

E. Lopez, E. Pozas, R. Rivera, and I. Ferrer, Bcl-2, Bax and Bcl-x expression following kainic acid administration at convulsant doses in the rat, Neuroscience, vol.91, pp.1461-1470, 1999.

L. J. Martin, Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism, J. Neuropathol. Exp. Neurol, vol.58, pp.459-471, 1999.

A. K. Merchant, T. L. Loney, and J. Maybaum, Expression of wild-type p53 stimulates an increase in both Bax and Bcl-xL protein content in HT29 cells, Oncogene, vol.13, pp.2631-2637, 1996.

D. E. Merry and S. J. Korsmeyer, Bcl-2 gene family in the nervous system, Annu. Rev. Neurosci, vol.20, pp.245-267, 1997.

T. Miyashita, S. Krajewski, M. Krajewska, H. G. Wang, H. K. Lin et al., Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene, vol.9, pp.1799-1805, 1994.

T. Miyashita, M. Harigai, M. Hanada, and J. C. Reed, Identification of a p53-dependent negative response element in the bcl-2 gene, Cancer Res, vol.54, pp.3131-3135, 1994.

T. Miyashita and J. C. Reed, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, vol.80, pp.293-299, 1995.

B. M. Morrison, W. G. Janssen, J. W. Gordon, and J. H. Morrison, Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice, J. Comp. Neurol, vol.391, pp.64-77, 1998.

X. Mu, J. He, D. W. Anderson, J. Q. Trojanowski, and J. E. Springer, Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons, Ann. Neurol, vol.40, pp.379-386, 1996.

D. W. Mulder, L. T. Kurland, K. P. Afford, and C. M. Beard, Familial adult motor neuron disease: Amyotrophic lateral sclerosis, Neurology, vol.36, pp.511-517, 1986.

Z. N. Oltvai, C. L. Milliman, and S. J. Korsmeyer, Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell, vol.74, pp.609-619, 1993.

C. Prives and P. A. Hall, The p53 pathway, J. Pathol, vol.187, pp.112-126, 1999.

M. E. Ripps, G. W. Huntley, P. R. Hof, J. H. Morrison, and J. W. Gordon, Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis, Proc. Natl. Acad. Sci. USA, vol.92, pp.689-693, 1995.

D. R. Rosen, T. Siddique, D. Patterson, D. A. Figlewics, P. Sapp et al., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, vol.362, pp.59-62, 1993.

A. F. Schott, I. J. Apel, G. Nunez, and M. F. Clarke, Bcl-xL protects cancer cells from p53-mediated apoptosis, Oncogene, vol.11, pp.1389-1394, 1995.

G. Shaulsky, N. Goldfinger, M. S. Tosky, A. J. Levine, and V. Rotter, Nuclear localization is essential for the activity of p53 protein, Oncogene, vol.6, pp.2055-2065, 1991.

S. Y. Shieh, M. Ikeda, Y. Taya, and C. Prives, DNA damageinduced phosphorylation of p53 alleviates inhibition by MDM2, Cell, vol.91, pp.325-334, 1997.

K. S. Shindler, C. B. Latham, and K. A. Roth, Bax deficiency prevents the increased cell death of immature neurons in bcl-xdeficient mice, J. Neurosci, vol.17, pp.3112-3119, 1997.

T. Siddique, Molecular genetics of familial amyotrophic lateral sclerosis, Adv. Neurol, vol.56, pp.227-231, 1991.

R. S. Slack, D. J. Belliveau, M. Rosenberg, J. Atwal, R. Aloyz et al., Adenovirus-mediated gene transfer of the tumor suppressor p53 induces apoptosis in postmitotic neurons, J. Cell Biol, vol.135, pp.1085-1096, 1996.

K. Vekrellis, M. J. Mccarthy, A. Watson, J. Whitfield, L. L. Rubin et al., Bax promotes neuronal cell death and is downregulated during the development of the nervous system, Development, vol.124, pp.1239-1249, 1997.

S. Vukosavic, M. Dubois-dauphin, N. Romero, and S. Przedborski, Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis, J. Neurochem, vol.73, pp.2460-2468, 1999.

P. C. Wong, C. A. Pardo, D. R. Borchelt, M. K. Lee, N. G. Copeland et al., An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria, Neuron, vol.14, pp.1105-1116, 1995.

Y. Yin, Y. Terauchi, G. G. Solomon, S. Aizawa, P. N. Rangarajan et al., Involvement of p85 in p53-dependent apoptotic response to oxidative stress, Nature, vol.391, pp.707-710, 1998.

Q. Zhan, I. Alamo, K. Yu, L. H. Boise, B. Cherney et al., The apoptosis-associated gamma-ray response of Bcl-x(L) depends on normal p53 function, Oncogene, vol.13, pp.2287-2293, 1996.